Impact of the implementation of a Fracture Liaison Service on pharmaceutical expenses for osteoporosis compared to an area without an FLS.

Antonio NaranjoSoledad Ojeda-BrunoAida SaavedraAmparo MolinaMiguel Angel Negrín

Published in: Expert review of pharmacoeconomics & outcomes research (2018)

The implantation of an FLS did not lead to an increase in pharmaceutical expenditures for OP over the 5-year period compared to the standard care provided for secondary fracture preventions.

Keyphrases

healthcare
quality improvement
mental health
palliative care
primary care
postmenopausal women
hip fracture
bone mineral density
pain management